Catalyst Wire Dossier Catalyst Wire Dossier

E7 T cell receptor T cells

E7 TCR-T cells · National Cancer Institute (NCI)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for E7 T cell receptor T cells, covering 2021-03-18 to 2021-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Immunotherapy With E7 T Cell Receptor T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions [Phase 2]

See pricing